Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019.

导出 OA

翻译打印收藏纠错

作者： Jiong,Yu ^[1] ; Xuan,Lu ^[2] ; Ling,Tong ^[1] ; Xiaowei,Shi ^[2] ; Jing,Ma ^[1] ; Feifei,Lv ^[3] ; Jian,Wu ^[2] ; Qiaoling,Pan ^[3] ; Jinfeng,Yang ^[3] ; Hongcui,Cao ^[1] ; Lanjuan,Li ^[4]

作者单位： State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd, Hangzhou City, 310003, China. ^[1] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Rd, Hangzhou City, 310003, China. ^[2] Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd, Hangzhou City, 310003, China. ^[3] Department of Laboratory Medicine, The First People's Hospital of Yancheng City, Yancheng City, 224005, China. ^[4]

关键词 COVID-19 SARS-CoV-2 interferon prognosis

主题词气雾剂(Aerosols);人类(Humans);重组蛋白质类(Recombinant Proteins);呼吸, 人工(Respiration, Artificial)

DOI 10.1111/bcp.14898

PMID 33982806

发布时间 2022-10-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交